Year: 2024

Jūratė Lingienė elected as the new Chairperson of the Board at AB “KN Energies”

Written by Customer Service on October 25, 2024. Posted in Public Companies.

AB “KN Energies” (further – KN or Company), the international operator of energy terminals, announces that by the decision of the Board on 25 October 2024, Jūratė Lingienė has been elected as the new Chairperson of the Board at KN Energies starting 1 November 2024, she previously served as an independent member of the Board of the Company. J. Lingienė has spent most of her professional career at SEB Group in Lithuania, Latvia and Sweden, where she has held the position of Head of the Finance Department, was responsible for the development of the SEB Service Centre in Lithuania and Latvia, served as a member of the Board of SEB Latvia and as the Director of Finance. Since 2015, she has been the Head of Finance, Technology and Business Support at SEB Group Headquarters. Her responsibilities also include operational risk...

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Written by Customer Service on October 25, 2024. Posted in Mergers And Acquisitions.

DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the acquisition of EpiCapture Limited, a company developing a non-invasive test for monitoring the risk of aggressive prostate cancer. This acquisition marks Trinity Biotech’s strategic expansion into the oncology diagnostics market. Prostate cancer is the most common non-skin cancer among men in the U.S., with about 1 in 8 men diagnosed during their lifetime and the cost for diagnosis and treatment estimated at over approximately $10 billion annually. The ability to accurately monitor prostate cancer progression is critical, as the disease can often be slow-growing, and unnecessary invasive interventions,...

PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group

Written by Customer Service on October 25, 2024. Posted in Mergers And Acquisitions.

EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the successful completion of its acquisition by Bansk Group (“Bansk”), a consumer-focused private investment firm dedicated to building distinctive consumer brands, in an all-cash transaction valued at approximately $1.5 billion. PetIQ stockholders will receive $31.00 in cash per PetIQ share in accordance with the terms of the transaction. With the completion of the transaction, PetIQ shares no longer trade on and will be delisted from the Nasdaq stock exchange. PetIQ is now a privately held company and continues to be operated independently by the Company’s executive team. “We’re pleased to have delivered significant value for PetIQ stockholders...

First Hawaiian, Inc. Reports Third Quarter 2024 Financial Results and Declares Dividend

Written by Customer Service on October 25, 2024. Posted in Dividend Reports And Estimates.

HONOLULU, Oct. 25, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended September 30, 2024. “I’m happy to report that we had a very good third quarter,” said Bob Harrison, Chairman, President, and CEO. “Net interest income and noninterest income increased over the prior quarter, expenses were well controlled and credit quality remained excellent. I’m also pleased to report that during the third quarter, Moody’s reviewed and reaffirmed all of First Hawaiian Bank’s long-term credit and deposit ratings.” On October 23, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on November 29, 2024, to stockholders of record at the close of business on November 18, 2024. Third...

Journey Medical Corporation Announces DFD-29 Data Presented at 44th Fall Clinical Dermatology Conference

Written by Customer Service on October 25, 2024. Posted in Public Companies.

Poster Presented on Dermal and Systemic Pharmacokinetics of Oral DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) versus Oral Doxycycline 40 mg Capsules (Oracea®) in Healthy Subjects With its modified-release formulation, DFD-29 (40 mg) provides higher dermal concentration than doxycycline from Day 1 onward at a similar dose, expected to translate into a clinically meaningful impact for treating patients with rosacea New Drug Application for DFD-29 under review by FDA with PDUFA goal date of November 4, 2024 SCOTTSDALE, Ariz., Oct. 25, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today...

Empty Capsules Market to Grow at USD 4.96 Billion by 2031 |SkyQuest Technology

Written by Customer Service on October 25, 2024. Posted in Mergers And Acquisitions.

The demand for empty capsules market is rapidly increasing as the demand for pharmaceutical drug is substantially high and capsules are the most preferred drug delivery system. Westford, USA, Oct. 25, 2024 (GLOBE NEWSWIRE) — Empty Capsules Market size was valued at USD 2.89 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR of 7% during the forecast period (2024-2031). The demand for empty capsules market is rapidly increasing as the demand for pharmaceutical drug is substantially high and capsules are the most preferred drug delivery system. Empty capsules are shells made of chemically less reactive materials such as gelatin, pullulan, or starch which are coated with a film. These shells are used to store and package pharmaceutically actives or nutraceutical formulations to be delivered inside the blood stream. Empty...

Circuit Breaker Market to Exceed Market Valuation USD 9.4 Billion by 2031 | SkyQuest Technology

Written by Customer Service on October 25, 2024. Posted in Mergers And Acquisitions.

Westford USA, Oct. 25, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global circuit breaker market will reach a value of USD 9.4 Billion by 2031, with a CAGR of 5.0% during the forecast period (2024-2031). The circuit breaker market has been witnessing remarkable growth backed by mounting demand for electricity and the growing need for efficient and reliable energy distribution systems. The leading market drivers comprise improvements in smart grid technologies, advances in smart grid technology, and rising infrastructure development. Overall, the market will continue to transform with more innovations in circuit breaker technology and favorable regulations for energy efficiency. Download a detailed overview: https://www.skyquestt.com/sample-request/circuit-breaker-market Browse in-depth TOC on the “Circuit Breaker Market” Pages...

Pacific Financial Corp Earns $2.6 Million, or $0.25 per Diluted Share for Third Quarter 2024; Tangible Book Value Per Share Up 6.6% During Quarter; Board of Directors Declares Quarterly Cash Dividend of $0.14 per Share

Written by Customer Service on October 25, 2024. Posted in Earnings Releases And Operating Results.

ABERDEEN, Wash., Oct. 25, 2024 (GLOBE NEWSWIRE) — Pacific Financial Corporation (OTCQX: PFLC), (“Pacific Financial”) or the (“Company”), the holding company for Bank of the Pacific (the “Bank”), reported net income of $2.6 million, or $0.25 per diluted share for the third quarter of 2024, compared to $2.1 million, or $0.21 per diluted share for the second quarter of 2024, and $3.6 million, or $0.35 per diluted share for the third quarter of 2023. All results are unaudited. Pacific Financials’ third quarter 2024 operating results reflected the following changes from the second quarter of 2024: (1) higher net interest income as the rise in loan and investment yields outpaced the rise in deposit and borrowing costs; (2) a negative provision for credit losses due to lower provision for unfunded loans; (3) lower non-interest income...

Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024

Written by Customer Service on October 25, 2024. Posted in Public Companies.

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the Jefferies London Healthcare Conference, November 19-20, 2024. Members of the management team will host one-on-one meetings on both days. Alvotech will be presenting at the conference on Tuesday, November 19, 2024 at 9:00-9:25 am GMT. An audio webcast of the conference presentation will also be available to investors and the general public and can be accessed in the Investors Section of Alvotech’s website under News and Events – Events and Presentations. After the event, a recording will also be available for 90 days. About AlvotechAlvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar medicines...

Abercrombie & Fitch Co. to Report Third Quarter 2024 Results on November 26, 2024

Written by Customer Service on October 25, 2024. Posted in Public Companies.

NEW ALBANY, Ohio, Oct. 25, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings conference call for all interested parties on Tuesday, November 26, 2024, at 8:30 a.m. ET. A press release detailing the company’s third quarter results is expected to be issued shortly after 7:30 a.m. ET. In addition, a presentation of the third quarter results will be available on the company’s website at approximately 7:30 a.m. ET.Conference Call: To access the conference call by phone, participants will need to register to obtain a dial-in phone number and an access code. Register for the call using this link. Webcast: To listen to a live webcast of the call, please visit corporate.abercrombie.com/investors/news-and-events/events/ and click the link to the webcast. Replay: A replay...

Year: 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals